Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	16.23B
Revenue (ttm)	5.27B
Net Income (ttm)	656.94M
Shares Out	881.71M
EPS (ttm)	0.74
PE Ratio	24.91
Forward PE	16.89
Dividend	0.40 (2.17%)
Ex-Dividend Date	Jun 19, 2025

Volume	22,524,985
Average Volume	47,356,048
Open	18.45
Previous Close	18.43
Day's Range	18.19 - 18.45
52-Week Range	11.83 - 19.98
Beta	0.37
RSI	56.47
Earnings Date	Aug 6, 2025

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 5,001
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2024, SHA:603456's revenue was 5.16 billion, a decrease of -6.57% compared to the previous year's 5.52 billion. Earnings were 606.10 million, a decrease of -41.34%.